These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12039925

  • 1. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study.
    Neugut AI, Fleischauer AT, Sundararajan V, Mitra N, Heitjan DF, Jacobson JS, Grann VR.
    J Clin Oncol; 2002 Jun 01; 20(11):2643-50. PubMed ID: 12039925
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.
    Iwashyna TJ, Lamont EB.
    J Clin Oncol; 2002 Oct 01; 20(19):3992-8. PubMed ID: 12351596
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
    De Stefano A, Moretto R, Bucci L, Pepe S, Romano FJ, Cella AC, Attademo L, Rosanova M, De Falco S, Fiore G, Raimondo L, De Placido S, Carlomagno C.
    Clin Colorectal Cancer; 2014 Sep 01; 13(3):185-91. PubMed ID: 25080847
    [Abstract] [Full Text] [Related]

  • 4. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.
    Dobie SA, Warren JL, Matthews B, Schwartz D, Baldwin LM, Billingsley K.
    Cancer; 2008 Feb 15; 112(4):789-99. PubMed ID: 18189291
    [Abstract] [Full Text] [Related]

  • 5. Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy.
    Huang XZ, Gao P, Song YX, Sun JX, Chen XW, Zhao JH, Ma B, Wang J, Wang ZN.
    Oncotarget; 2016 Apr 12; 7(15):19643-53. PubMed ID: 26910371
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant therapy for colon and rectal cancer.
    Ratkin GA.
    Am Fam Physician; 1997 May 15; 55(7):2487-92, 2495-6. PubMed ID: 9166147
    [Abstract] [Full Text] [Related]

  • 7. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.
    Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI.
    Ann Intern Med; 2002 Mar 05; 136(5):349-57. PubMed ID: 11874307
    [Abstract] [Full Text] [Related]

  • 8. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Xu Z, Mohile SG, Tejani MA, Becerra AZ, Probst CP, Aquina CT, Hensley BJ, Arsalanizadeh R, Noyes K, Monson JR, Fleming FJ.
    Cancer; 2017 Jan 01; 123(1):52-61. PubMed ID: 27560162
    [Abstract] [Full Text] [Related]

  • 9. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study.
    Sundararajan V, Grann VR, Jacobson JS, Ahsan H, Neugut AI.
    Cancer J; 2001 Jan 01; 7(3):213-8. PubMed ID: 11419029
    [Abstract] [Full Text] [Related]

  • 10. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun 01; 25(3):91-103. PubMed ID: 7596054
    [Abstract] [Full Text] [Related]

  • 11. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ.
    Dis Colon Rectum; 2004 Dec 01; 47(12):2025-31. PubMed ID: 15657650
    [Abstract] [Full Text] [Related]

  • 12. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, Ghadimi M, Wolff HA, Lang-Welzenbach M, Raab HR, Wittekind C, Ströbel P, Staib L, Wilhelm M, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R, Liersch T, German Rectal Cancer Study Group.
    Lancet Oncol; 2015 Aug 01; 16(8):979-89. PubMed ID: 26189067
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE, O'Connell M, Niedzwiecki D, Hollis DR, Benson AB, Cummings B, Gunderson LL, Macdonald JS, Martenson JA, Mayer RJ.
    J Clin Oncol; 2002 Apr 01; 20(7):1744-50. PubMed ID: 11919230
    [Abstract] [Full Text] [Related]

  • 14. Carcinoma microsatellite instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for stage II rectal cancer.
    Yang L, Sun Y, Huang XE, Yu DS, Zhou JN, Zhou X, Li DZ, Guan X.
    Asian Pac J Cancer Prev; 2015 Apr 01; 16(4):1545-51. PubMed ID: 25743829
    [Abstract] [Full Text] [Related]

  • 15. The use of capecitabine in the combined-modality therapy for rectal cancer.
    Liauw SL, Minsky BD.
    Clin Colorectal Cancer; 2008 Mar 01; 7(2):99-104. PubMed ID: 18501068
    [Abstract] [Full Text] [Related]

  • 16. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.
    Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB.
    J Clin Oncol; 2001 Sep 01; 19(17):3712-8. PubMed ID: 11533092
    [Abstract] [Full Text] [Related]

  • 17. Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study.
    Bergquist JR, Thiels CA, Shubert CR, Habermann EB, Hayman AV, Zielinski MD, Mathis KL.
    World J Surg; 2016 Feb 01; 40(2):447-55. PubMed ID: 26566779
    [Abstract] [Full Text] [Related]

  • 18. The postoperative adjuvant radiation therapy and radiochemotherapy for UICC stage II and III rectal cancer. A retrospective analysis.
    Bagatzounis A, Willner J, Oppitz U, Flentje M.
    Strahlenther Onkol; 2000 Mar 01; 176(3):112-7. PubMed ID: 10742831
    [Abstract] [Full Text] [Related]

  • 19. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 20. Postoperative 5-FU based radiochemotherapy in rectal cancer: retrospective long term results and prognostic factors of a pooled analysis on 1,338 patients.
    Genovesi D, Myerson RJ, Cèfaro GA, Vinciguerra A, Augurio A, Trignani M, DI Tommaso M, Nuzzo M, Lupattelli M, Aristei C, Bellavita R, Scandolaro L, Cosentino D, Pani G, Ziccarelli L, Gambacorta MA, Barba MC, Maranzano E, Trippa F, Sciacero P, Niespolo R, Leonardi C, Iannone T, Rosetto ME, Fusco V, Sanpaolo P, Melano A, Valvo F, Capirci C, DE Paoli A, DI Nicola M, Mantello G, Valentini V, G.I. A.I.R.O. Working Group.
    Anticancer Res; 2013 Oct 01; 33(10):4557-66. PubMed ID: 24123031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.